OAB-004: Carfilzomib-based Induction/consolidation with or Without Autologous Transplant and Lenalidomide (R) or Carfilzomib-Lenalidomide (KR) Maintenance: Efficacy in High-Risk Patients of the FORTE Study
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined